Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 1
2004 2
2005 1
2006 2
2007 1
2011 1
2012 1
2016 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Restless legs syndrome induced by fexofenadine/pseudoephedrine.
Nishioka H, Kanzawa Y. Nishioka H, et al. J Gen Fam Med. 2020 Jun 15;21(6):256-257. doi: 10.1002/jgf2.338. eCollection 2020 Nov. J Gen Fam Med. 2020. PMID: 33304720 Free PMC article.
Antihistamines are known risk factors for restless legs syndrome (RLS). However, reports on RLS associated with fexofenadine or its combinations are rare. Here, we report a 30-year-old woman with RLS that was induced by fexofenadine/pseudoephedrine. .. …
Antihistamines are known risk factors for restless legs syndrome (RLS). However, reports on RLS associated with fexofenadine or its …
Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis.
Mansfield LE. Mansfield LE. Expert Opin Pharmacother. 2006 May;7(7):941-51. doi: 10.1517/14656566.7.7.941. Expert Opin Pharmacother. 2006. PMID: 16634716 Review.
A new once-daily fexofenadine/pseudoephedrine combination has been developed and recently approved in the US. The combination provides an effective, well-tolerated antihistamine and a reliable, sustained-release pseudoephedrine system. ...
A new once-daily fexofenadine/pseudoephedrine combination has been developed and recently approved in the US. The co …
Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G. Berkowitz RB, et al. Clin Ther. 2006 Oct;28(10):1658-69. doi: 10.1016/j.clinthera.2006.10.023. Clin Ther. 2006. PMID: 17157121 Clinical Trial.
BACKGROUND: The onset of action of antihistamine-decongestant combinations is an important factor in the treatment of subjects with seasonal allergic rhinitis (SAR). OBJECTIVE: This was a pooled analysis of 2 published studies with identical designs investigating the onset …
BACKGROUND: The onset of action of antihistamine-decongestant combinations is an important factor in the treatment of subjects with s …
[Clinical Management of Japanese Cedar Pollinosis].
Sawatsubashi M. Sawatsubashi M. Fukuoka Igaku Zasshi. 2016 Jan;107(1):1-7. Fukuoka Igaku Zasshi. 2016. PMID: 27333653 Free article. Review. Japanese. No abstract available.
Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.
Maggio RM, Castellano PM, Vignaduzzo SE, Kaufman TS. Maggio RM, et al. J Pharm Biomed Anal. 2007 Dec 21;45(5):804-10. doi: 10.1016/j.jpba.2007.07.024. Epub 2007 Jul 27. J Pharm Biomed Anal. 2007. PMID: 17766076
An alternative method for the determination of fexofenadine (FEX) and pseudoephedrine (PSE) in their combined tablet formulation has been developed, employing the partial least squares (PLS) analysis of spectral data of the analytes in their pharmaceutical as …
An alternative method for the determination of fexofenadine (FEX) and pseudoephedrine (PSE) in their combined tablet fo …
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Simpson K, Jarvis B. Simpson K, et al. Drugs. 2000 Feb;59(2):301-21. doi: 10.2165/00003495-200059020-00020. Drugs. 2000. PMID: 10730552
When given in combination, fexofenadine and extended release pseudoephedrine had complementary activity. ...In those with excessive nasal congestion the combination of fexofenadine plus pseudoephedrine may be useful. In clinical trials …
When given in combination, fexofenadine and extended release pseudoephedrine had complementary activity. ...In those wi …
The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL, Mason J, Compton D, Stewart J, Ricard N. Sussman GL, et al. J Allergy Clin Immunol. 1999 Jul;104(1):100-6. doi: 10.1016/s0091-6749(99)70120-x. J Allergy Clin Immunol. 1999. PMID: 10400846 Clinical Trial.
OBJECTIVE: We sought to compare the efficacy and safety of a fexofenadine HCl/pseudoephedrine HCl combination with that of each individual component in the treatment of ragweed allergy. METHODS: In this Canadian multicenter, double-blind, parallel-group study …
OBJECTIVE: We sought to compare the efficacy and safety of a fexofenadine HCl/pseudoephedrine HCl combination with that …
Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G. Berkowitz RB, et al. Allergy Asthma Proc. 2004 Sep-Oct;25(5):335-43. Allergy Asthma Proc. 2004. PMID: 15603207 Clinical Trial.
Although antihistamine-decongestant combinations are frequently used for allergic rhinitis, published data about the onset of action of these combination agents are limited. ...The incidence of adverse events was 1.6 and 3.3% for the combination and placebo, …
Although antihistamine-decongestant combinations are frequently used for allergic rhinitis, published data about the onset of action …
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Moinuddin R, et al. Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9. doi: 10.1016/S1081-1206(10)61713-9. Ann Allergy Asthma Immunol. 2004. PMID: 14756468 Clinical Trial.
OBJECTIVE: To compare the 2 combinations in the treatment of seasonal allergic rhinitis. METHODS: This was a randomized, double-blind, double-dummy, parallel study in which patients with seasonal allergic rhinitis received either fexofenadine, 60 mg, and pseudoep …
OBJECTIVE: To compare the 2 combinations in the treatment of seasonal allergic rhinitis. METHODS: This was a randomized, double-blind …
Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB, Woodworth GG, Lutz C, Weiler K, Weiler J, Moss M, Meeves S. Berkowitz RB, et al. Ann Allergy Asthma Immunol. 2002 Jul;89(1):38-45. doi: 10.1016/S1081-1206(10)61909-6. Ann Allergy Asthma Immunol. 2002. PMID: 12141718 Clinical Trial.
Decrease in headache with fexofenadine-pseudoephedrine versus placebo began 45 minutes postdose (P = 0.0425). Incidence of treatment-related adverse events was 1.4% for fexofenadine-pseudoephedrine and 3.3% for placebo. CONCLUSIONS: Fexofenadine …
Decrease in headache with fexofenadine-pseudoephedrine versus placebo began 45 minutes postdose (P = 0.0425). Incidence of tre …
13 results